Company: PACB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001299130-25-000156
Chunk: 40

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
)35 — (267)— Consolidated net loss(41,930)(173,319)(468,005)(251,497)A summary of our revenue by geographic location is as follows:Three Months Ended June 30,Six Months Ended June 30,(In thousands)2025202420252024Americas$17,687 $20,757 $33,990 $38,435 Europe, Middle East and Africa9,467 7,022 18,707 15,378 Asia-Pacific12,612 8,234 24,222 21,010 Total revenue$39,766 $36,013 $76,919 $74,823 A summary of our revenue by category is as follows:   Three Months Ended June 30,Six Months Ended June 30,(In thousands)2025202420252024Instrument revenue$14,150 $14,678 $25,166 $33,703 Consumable revenue18,933 17,068 39,030 33,052 Product revenue33,083 31,746 64,196 66,755 Service and other revenue6,683 4,267 12,723 8,068 Total revenue$39,766 $36,013 $76,919 $74,823 

Q2 Fiscal 2025 Form 10-Q26

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with (i) our unaudited condensed consolidated financial statements and related notes that are included elsewhere in this Quarterly Report on Form 10-Q and (ii) our 2024 Annual Report filed with the U.S. Securities and Exchange Commission, or the SEC, on March 17, 2025. This discussion contains forward-looking statements based upon current plans, expectations and beliefs that involve risks and uncertainties. The words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “might,” “plans,” “potential,” “predicts,” “projects,” “seeks,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual results may differ materially from those